At a glance
ClinicalIndex Comparison RecordN/ACompleted· 27 enrolled
Drug / intervention
Contralateral Esophageal Sparing Technique (CEST)radiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase I Trial Of Intensity-Modulated Radiation Therapy (IMRT) Using A Contralateral Esophagus Sparing Technique (CEST) In Locally Advanced Non-Small Cell Lung Cancer (NSCLC) And Limited-Stage Small Cell Lung Cancer (LS-SCLC).
In Brief
A clinical study evaluating Contralateral Esophageal Sparing Technique (CEST) for Non-small Cell Lung Carcinoma and Small Cell Lung Carcinoma. Completed, enrolled 27 participants across 2 sites.
Detailed Summary
This research study is examining the benefit of a novel radiation planning approach on the likelihood of developing severe esophagitis (irritation and inflammation of the esophagus) during the course of radiation therapy with concurrent chemotherapy which is associated with very painful and difficult swallowing.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedMar 2015
Enrollment StartJun 2015
Primary CompletionFeb 2019
Study CompletionMar 2021
TodayJul 2026
First PostedMar 20, 2015
Enrollment StartJun 1, 2015
Primary CompletionFeb 1, 2019
Study CompletionMar 1, 2021
TodayJul 2, 2026
Enrollment to primary: 3.7 yearsPosted 11.3 years ago
Interventions
Contralateral Esophageal Sparing Technique (CEST)radiation
Determine whether CEST decreases rate of severe acute esophagitis